期刊文献+

RET原癌基因突变致多发性内分泌腺瘤病2b型临床诊治 被引量:3

Diagnosis and Therapy of Multiple Endocrine Neoplasia Type 2b Induced by RET Proto-oncogene Mutation
暂未订购
导出
摘要 多发性内分泌腺瘤病(MEN)2b型是RET基因突变引起的常染色体显性遗传病,常见临床表型为甲状腺髓样癌(MTC)、嗜铬细胞瘤、多发性黏膜神经瘤和类马凡体型,各表型可同时或先后发生,易漏诊。本文分析了1例MEN2b型患者病史、诊断、治疗及随访资料。本例患者1995年无诱因出现颈部增粗,诊断为"右甲状腺腺瘤";1999年发现"左侧甲状腺占位";2000年发现舌、唇黏膜增厚并突起小肿物,肿物渐增大;2009年及2010年分别行左、右肾上腺肿物切除,术后病理示:嗜铬细胞瘤。本次入院行下唇内侧局部小突起切除和双侧甲状腺次全切除术,术后病理示:舌黏膜神经瘤、MTC。患者基因测序发现RET基因第16号外显子918密码子突变(M918T),患者父母、兄均未出现MEN2b表型特征,基因检测无异常发现。患者MTC术后1年降钙素水平仍高于参考值,结合肺部CT检查结果,考虑MTC肺部转移可能性较大。 Multiple Endocrine Neoplasia Type 2b (MEN2b) is a autosomal dominant inherited disease induced by RET proto - oncogene mutation. Its common clinical phenotypes include medullary thyroid carcinoma (MTC), pheochromocytoma, multiple mucosal neuromas and body type like marfan syndrome. These phenotypes occur concurrently or successively, which may cause miss diagnosis. In this study, we analyzed the medical history, diagnosis, treatment and follow -up data of a patient with MEN2b. In 1995, neck enlargement occurred in the patient without inducement, and it was diagnosed as " adenoma in the right thyroid". In 1999 ," space Occupying lesion in the left thyroid" was found in the patient. In 2000, labium mucosa became thick and small mass was found on it with the mass enlarging gradually. The excision of left adrenal masses and the excision of right adrenal masses were conducted in 2009 and 2010 respectively, and the lesion was diagnosed as pheochromocytoma by postoperative pathological analysis. During the hospital visit of the patient when the research was conducted, local small protrusions on the inner side of the underlip were excised, and bilateral subtotal thyroideetomy was also conducted. After these surgeries, the lesions were diagnosed as tongue mucosa neuroma and MTC. By gene sequencing of the patient, we noted the mutation of eodon 918 in exon 16 of RET gene. The parents and brothers of the patient showed no phenotypic characteristic of MEN2b and no abnormalities in gene sequencing. One year after MTC surgery, the level of calcitonin was still higher than the reference value, which, combined with the examination results of lung CT scanning, indicated great possibility of lung metastasis from MTC.
出处 《中国全科医学》 CAS CSCD 北大核心 2016年第2期229-232,共4页 Chinese General Practice
关键词 多发性内分泌腺瘤病2b型 甲状腺肿瘤 嗜铬细胞瘤 RET基因 突变 Multiple endocrine neoplasia type 2b Thyroid neoplasms Pheochromocytoma RET gene Mutation
  • 相关文献

参考文献17

  • 1Steiner AL, Goodman AD, Powers SR. Study of a kindred with pheochromocytnma, medunary thyroid carcinoma, hyperparathyroidism, and Cushing's disease:'mutiple endocrine neopIasia, type 2 [ J]. Medicine (Baltimore) , 1968, 47 (5) : 371 - 409.
  • 2Carney JA, Go VL, Sizemore GW, et al. Alimentary - tract ganglioneuromatosis. A major component of the syndrome of multiple endocrine neoplasia, type 2b [ J]. N Engl J Med, 1976, 295 (23): 1287 -1291.
  • 3Raue F, Frank - Raue K. Multiple endocrine neoplasia type 2 : 2007 update [J]. Horm Res, 2007, 68 (Suppl5): 101-104.
  • 4Eng C, Clayton D, Schuffeneeker I, et al. The relationship between specific RET proto - oneogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis [J]. JAMA, 1996, 276 (19): 1575 -1579.
  • 5Kouvaraki MA, Shapiro SE, Perrier ND, et al. RET proto - oncogene : a review and update of genotype - phenotype correlations inhereditary medullary thyroid cancer and associated endocrine tumors [J~. Thyroid, 2005, 15 (6): 531-544.
  • 6Toledo SP, dos Santos MA, Toledo Rde A, et al. Impact of RET proto - oncogene analysis on the clinical management of multiple endocrine neoplasia type 2 [ J~. Clinics (Sao Paulo), 2006, 61 (1) : 59 -70.
  • 7Frank- Raue K, Rondot S, Schulze E, et al. Change in the spectrum of RET mutations diagnosed between 1994 and 2006 E J]- Clin Lab, 2007, 53 (5/6) : 273 - 282.
  • 8Neumann HP, Eng C, Mulligan LM, et al. Consequences of direct genetic testing for germline mutations in the clinical management of families with multipleendocrine neoplasia, type lI [ J 1. JAMA, 1995, 274 (14): 1149 -1151.
  • 9Dora JM, Canalli MH, Capp C, et al. Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: ease report and review of the literature ~ J ]. Thyroid, 2008, 18 (8): 895-899.
  • 10Chen H, Sippel RS, O'Dorisio MS, et al. The North American Neuroendocrine Tumor Society consensus guidehne for the diagnosis and management of neuroendocrine tumors: pheochromocytoma, paraganglioma, and medullary thyroid cancer [ J ]. Pancreas, 2010, 39 (6): 775-783.

二级参考文献18

  • 1吴毅.甲状腺髓样癌的外科治疗[J].中国普外基础与临床杂志,2006,13(3):250-251. 被引量:3
  • 2高再荣,安锐,张永学,Hans J.Biersack.核素靶向治疗在转移性甲状腺髓样癌治疗中的价值[J].中华肿瘤杂志,2006,28(8):621-624. 被引量:8
  • 3Kebebew E, ltuarte PH, Siperstein AE, et al. Medullary thyroid carcinoma : clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer, 2000, 88: 1139-1148.
  • 4Scopsi L, Sampietro G, Boracchi P, et al. Multivariate analysis of prognostic factors in sporadic medullary carcinoma of the thyroid. A retrospective study of 109 consecutive patients. Cancer, 1996, 78 : 2173-2183.
  • 5Fuchshuber PR, Loree TR, Hicks WL Jr, et al. Medullary carcinoma of the thyroid: prognostic factors and treatment recommendations. Ann Surg Oncol, 1998, 5:81-86.
  • 6Modigliani E, Cohen R, Campos JM, et al. Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'etude des tumeurs acalcitonine. Clin Endoerinol ( Oxf), 1998, 48: 265 -273.
  • 7Hazard JB, Hawk WA, Crile G Jr. Medullary (solid) carcinoma of the thyroid; a clinicopathologie entity. J Chn Endocrinol Metab, 1959, 19: 152-161.
  • 8Corsello SM, Lovicu RM, Migneco MG, et al. Diagnostic approach, genetic screening and prognostic factors of medullary thyroid carcinoma. Rays, 2000, 25:257-266.
  • 9Dottorini ME, Assi A, Sironi M, et al. Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables. Cancer, 1996, 77 : 1556-1565.
  • 10Cohen R, Campos JM, Salaun C, et al. Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Greupe d' Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab,2000, 85:919-922.

共引文献4

同被引文献33

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部